Kaketsuken Becomes First Japanese Pharmaceutical Company to Implement Medidata Solutions, Inc.’s Integrated Solutions for Randomization, Trial Supply Management and Clinical Data Collection, Management and Reporting in Japanese Trials
10/1/2012 10:19:05 AM
More...
|
XOMA (US) LLC (XOMA) (JOBS) Signs Antibody Discovery Collaboration With Kaketsuken; XOMA to Get $8 Million
11/3/2009 6:23:40 AM
More...
|
Vivalis: GlaxoSmithKline (GSK) And Kaketsuken Will Co-Develop EB66 Cell Based Flu Vaccines
9/29/2009 10:28:42 AM
More...
|
Vivalis and Kaketsuken Extend their Collaboration in the Tetsing of Vivalis EBx(R) Cells
1/29/2008 12:21:12 PM
More...
|
VaxGen, Inc. (VXGN) and Kaketsuken End Smallpox Vaccine Partnership
6/11/2007 12:06:32 PM
More...
|